Cellular Immunology Laboratory, INMI L Spallanzani, IRCCS, Rome, Italy.
B cell Laboratory, Immunology Research Area, Bambino Gesú Children's Hospital, IRCCS, Rome, Italy.
Immunology. 2022 Nov;167(3):287-302. doi: 10.1111/imm.13564. Epub 2022 Sep 5.
The COVID-19 pandemic has represented an unprecedented challenge for the humanity, and scientists around the world provided a huge effort to elucidate critical aspects in the fight against the pathogen, useful in designing public health strategies, vaccines and therapeutic approaches. One of the first pieces of evidence characterizing the SARS-CoV-2 infection has been its breadth of clinical presentation, ranging from asymptomatic to severe/deadly disease, and the indication of the key role played by the immune response in influencing disease severity. This review is aimed at summarizing what the SARS-CoV-2 infection taught us about the immune response, highlighting its features of a double-edged sword mediating both protective and pathogenic processes. We will discuss the protective role of soluble and cellular innate immunity and the detrimental power of a hyper-inflammation-shaped immune response, resulting in tissue injury and immunothrombotic events. We will review the importance of B- and T-cell immunity in reducing the clinical severity and their ability to cross-recognize viral variants.
COVID-19 大流行是人类面临的前所未有的挑战,世界各地的科学家为阐明抗击病原体的关键方面做出了巨大努力,这些方面有助于制定公共卫生策略、疫苗和治疗方法。描述 SARS-CoV-2 感染的首批证据之一是其临床表现广泛,从无症状到严重/致命疾病,表明免疫反应在影响疾病严重程度方面起着关键作用。这篇综述旨在总结 SARS-CoV-2 感染教会我们的关于免疫反应的知识,强调其作为双刃剑的特征,既介导保护性又介导致病性过程。我们将讨论可溶性和细胞固有免疫的保护作用,以及导致组织损伤和免疫血栓形成事件的超炎症样免疫反应的有害力量。我们将回顾 B 细胞和 T 细胞免疫在降低临床严重程度及其识别病毒变体的能力方面的重要性。